Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study

Table 3 Treatment of recurrent intrahepatic cholangiocarcinoma

Treatment	n	Median DFS, mo (range)	MS after recurrence, mo (range)
Local therapy	14	6 (1-86)	3 (1-36)
Hepatectomy	2	10 (7-13)	25 (13-36)
TACE	8	3 (1-23)	2 (1-7)
RFA	4	7 (2-86)	3 (1-7)
Systemic therapy	22	5 (1-29)	4 (1-38)
Chemotherapy	3	11 (10-29)	4 (1-38)
Targeted therapy	12	3 (1-23)	4 (1-10)
Targeted + immunization therapy	7	4 (1-13)	7 (2-24)
Multimodality therapy	6	4 (2-11)	7 (4-24)
Best supportive care	12	6 (3-20)	1 (1-6)

N: Number; DFS: Disease-free survival; MS: Median survival; TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation.